基于逆向网络药理学和分子对接探讨电离辐射引发的造血急性辐射综合征的机制及相关中药预测

Investigating the mechanisms of hematopoietic acute radiation syndrome induced by ionizing radiation and predicting related traditional Chinese medicines based on reverse network pharmacology and molecular docking

  • 摘要:
    目的 探讨电离辐射(IR)引发造血急性辐射综合征(H-ARS)的机制并预测相关的治疗中药。
    方法 检索IR和H-ARS的靶点,将二者的交集靶点导入相互作用基因/蛋白质的搜索工具(STRING)数据库,筛选关键靶点,构建蛋白质-蛋白质相互作用网络。采用基因本体论(GO)和京都基因与基因组百科全书(KEGG)富集分析揭示其生物学意义,通过IR和H-ARS的关键靶点收集与其相关的活性成分,构建关键靶点-活性成分网络,选取网络中Degree值排名前5的关键靶点进行分子对接。通过与IR和H-ARS的关键靶点相关的活性成分筛选中药,构建关键靶点-活性成分-中药网络,对筛选出的中药的四气五味和归经规律进行分析。
    结果 IR与H-ARS的交集靶点共338个,关键靶点12个GO和KEGG富集分析分别得到1 658项和177项条目。12个关键靶点通过筛选匹配到100种有意义的活性成分。Degree值≥5的7种活性成分与Degree值排名前5的5个关键靶点进行了35次分子对接验证,活性成分与关键靶点间具有良好的结合活性。70种有意义的活性成分匹配到269种中药,其中Degree值≥3的中药有47种,药性以温、寒为主,药味以苦、辛居多,归经多分布于肺、肝、胃三经。
    结论 IR引发H-ARS的机制可能是通过调控磷脂酰肌醇3-激酶-蛋白激酶B信号通路(PI3K-Akt)、肿瘤相关等信号通路,干预细胞增殖、细胞生长、转录调控等关键生物学过程,诱导造血干祖细胞的损伤和造血微环境紊乱。预测347种可用于IR引发的H-ARS治疗的中药。

     

    Abstract:
    Objective To investigate the mechanisms by which ionizing radiation (IR) induces hematopoietic acute radiation syndrome (H-ARS) and to identify potential traditional Chinese medicinal treatments.
    Methods We identified targets associated with IR and H-ARS, imported the overlapping targets into the Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) database, analyzed and screened for key targets, and constructed a protein-protein interaction network. Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were used to elucidate their biological significance. Bioactive compounds associated with the key targets of IR and H-ARS were collected to construct a key target–bioactive compound network, and the top 5 key targets ranked by degree were selected for molecular docking. Traditional Chinese medicines were screened based on bioactive compounds associated with the key targets of IR and H-ARS, and a key-target–bioactive compound–traditional Chinese medicine network was constructed. The "Four Properties and Five Flavors" and meridian tropism patterns of the screened traditional Chinese medicines were analyzed.
    Results  A total of 338 overlapping targets were identified between IR and H-ARS, and GO and KEGG enrichment analyses yielded 1,658 and 177 entries, respectively. Through screening, 100 meaningful bioactive compounds were matched to 12 key targets. Seven bioactive compounds with a degree value ≥5 were used as small-molecule ligands for 35 molecular docking validation trials with the top 5 key targets ranked by degree value, yielding favorable results. Seventy meaningful bioactive compounds were matched to 269 traditional Chinese medicines. Among these, 47 traditional Chinese medicines had a "Degree" value ≥3; their properties were predominantly "warm" or "cold", their tastes were mostly "bitter" or "pungent", and they were primarily distributed among the lung, liver, and stomach meridians.
    Conclusions The mechanism by which IR induces H-ARS may involve regulating the phosphoinositide 3-kinase-protein kinase B (PI3K-Akt) signaling pathway and other tumor-related signaling pathways, thereby interfering with key biological processes such as cell proliferation, cell growth, and transcriptional regulation, and inducing damage to hematopoietic stem and progenitor cells and disruption of the hematopoietic microenvironment. The screened bioactive compounds (such as resveratrol, curcumin, and magnolol) and traditional Chinese medicines herbs with high Degree values (such as Polygonum cuspidatum, Ephedra, and Glycyrrhiza) may exert radioprotective and hematopoietic repair effects by targeting key targets such as signal transduction and transcription activator 3 (STAT3), the tumor protein p53 (TP53), and the RAC-α serine/threonine protein kinase (AKT1). Molecular docking results confirm that the active compounds exhibit strong binding affinity for these key targets.

     

/

返回文章
返回